Tag:
MediciNova
Latest Headlines
Latest Headlines
MediciNova shares crash after lead asthma drug fails IIb trial
While the CEO tried to put the data in context, offering reasons for optimism for a planned late-stage study of the lead program, investors watched the stock price crater more than 50% after the news hit.
MediciNova buys Avigen in $37M deal
MediciNova said today that it has finally worked out a deal to buy competing company Avigen for $37 million, or $1.24 per share. The deal represents a 7 percent discount tor Avigen's closing stock
MediciNova finally forges takeover deal for Avigen
After months of wrangling, MediciNova is close to completing a deal to acquire Avigen. The two companies have reached an "understanding" that values Alameda, CA-based Avigen at its liquidation price
Avigen rejects BVF takeover offer
Avigen has rejected a potential merger deal Biotechnology Value Fund (BVF). Late last month BFV offered $20.9 million for Avigen, which has been in a tough position since October when a mid-stage
Avigen shareholder pushes MediciNova merger
Avigen's largest shareholder is trying to engineer a merger of the developer with MediciNova. A subsidiary of Biotechnology Value Fund of San Francisco is offering $20.9 million for Avigen, but says
MediciNova delivers buyout offer to Avigen chair
On the same day that troubled Avigen was outlining its restructuring efforts and search for a buyer of all or party of the company, MediciNova says it sent the developer a buyout offer. No numbers
